CCI approves Manulife Asset Management’s acquisition of 49% shares in Mahindra Asset Management Company Private Limited and Mahindra Trustee Company Private Limited

Our undertakings for long-term impact are an organic extension of our purpose.

They are to employ our deep knowledge of the law beyond the business, the transaction, the deal. To use the opportunities and skills we possess, to reflect on the culture we’re creating. Individually and collectively, these are our efforts to help shape the thinking of our future generations, and arm them with strategies for true, sustainable growth.

Oct 18, 2019

CCI approves Manulife Asset Management’s acquisition of 49% shares in Mahindra Asset Management Company Private Limited and Mahindra Trustee Company Private Limited

On August 22, 2019, CCI approved the acquisition of 49% of the total equity share capital of Mahindra Asset Management Company Private Limited (‘Mahindra AMC’) and Mahindra Trustee Company Private Limited (‘Mahindra TCPL’) by Manulife Asset Management (Singapore) Pte. Ltd (‘MAMSG’). [1]

MAMSG is a wholly-owned subsidiary of Manulife Financial Asia Limited (an entity based in Hong Kong) and an indirect wholly-owned subsidiary of Manulife Financial Corporation, and is engaged in fund management services. Mahindra AMC is the investment manager for the Mahindra Mutual Fund. Mahindra TCPL is the trustee of Mahindra Mutual Fund.

CCI noted that there are no horizontal overlaps between the MAMSG, Mahindra AMC and Mahindra TCPL, either directly or indirectly (through their affiliates), and are also not engaged in any vertically overlapping business. Based on this, CCI held that the transaction is not likely to have an appreciable adverse effect on competition in India, and granted its approval.

[1] C-2019/07/673.

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.